Therapeutic Options in High-risk Non-muscle-invasive Bladder Cancer During the Current Worldwide Shortage of Bacille Calmette-Guerin

被引：61
|
作者：
Mostafid, A. Hugh [1 ]
Palou Redorta, Joan [2 ]
Sylvester, Richard [3 ]
Witjes, J. Alfred [4 ]
机构：
[1] Royal Surrey Cty Hosp, Dept Urol, Guildford, Surrey, England
[2] Univ Autonoma Barcelona, Dept Urol, Fundacio Puigvert, E-08193 Barcelona, Spain
[3] European Org Res Treatment Canc, Brussels, Belgium
[4] Radboud UMC, Dept Urol, Nijmegen, Netherlands
来源：
EUROPEAN UROLOGY | 2015年 / 67卷 / 03期
关键词：
TRANSITIONAL-CELL CARCINOMA; IMMUNOTHERAPY; MAINTENANCE; T1; TA;
D O I：
10.1016/j.eururo.2014.11.031
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 360
页数：2
相关论文
共 50 条
  • [1] Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guerin
    Packiam, Vignesh T.
    Johnson, Scott C.
    Steinberg, Gary D.
    CANCER, 2017, 123 (03) : 390 - 400
  • [2] Intravesical bacillus Calmette-Guerin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer
    Ekin, Rahmi Gokhan
    Akarken, Ilker
    Zorlu, Ferruh
    Tarhan, Huseyin
    Kucuk, Ulku
    Yildirim, Zubeyde
    Divrik, Rauf Taner
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (5-6): : E278 - E283
  • [3] Bacillus Calmette-Guerin Without Maintenance Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer
    Herr, Harry W.
    Dalbagni, Guido
    Donat, Sherri M.
    EUROPEAN UROLOGY, 2011, 60 (01) : 32 - 36
  • [4] Effect of Bacille Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer After Prostate Radiotherapy
    Durant, Adri M.
    Lee, Yeonsoo S.
    Mi, Lanyu
    Faraj, Kassem
    Lyon, Timothy D.
    Singh, Parminder
    Tyson, Mark D., II
    BLADDER CANCER, 2024, 10 (01) : 35 - 45
  • [5] The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?
    Hofbauer, Sebastian L.
    Shariat, Shahrokh F.
    Chade, Daher C.
    Sarkis, Alvaro S.
    Ribeiro-Filho, Leopoldo A.
    Nahas, Willian C.
    Klatte, Tobias
    UROLOGIA INTERNATIONALIS, 2016, 96 (01) : 46 - 50
  • [6] Theories behind Bacillus Calmette-Guerin failure in high-risk non-muscle-invasive bladder cancer and update on current management
    Maroof, Hanna
    Paramore, Louise
    Ali, Ahmed
    CANCER PATHOGENESIS AND THERAPY, 2024, 2 (02): : 74 - 80
  • [7] Failure of bacille Calmette-Guerin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: an update of available treatment options
    Yates, David R.
    Roupret, Morgan
    BJU INTERNATIONAL, 2010, 106 (02) : 162 - 167
  • [8] Gemcitabine Versus Bacille Calmette-Guerin After Initial Bacille Calmette-Guerin Failure in Non-Muscle-Invasive Bladder Cancer A Multicenter Prospective Randomized Trial
    Di Lorenzo, Giuseppe
    Perdona, Sisto
    Damiano, Rocco
    Faiella, Adriana
    Cantiello, Francesco
    Pignata, Sandro
    Ascierto, Paolo
    Simeone, Ester
    De Sio, Marco
    Autorino, Riccardo
    CANCER, 2010, 116 (08) : 1893 - 1900
  • [9] Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guerin?
    Lobo, Niyati
    Hensley, Patrick J.
    Bree, Kelly K.
    Nogueras-Gonzalez, Graciela M.
    Navai, Neema
    Dinney, Colin P.
    Kamat, Ashish M.
    BJU INTERNATIONAL, 2022, 130 (04) : 463 - 469
  • [10] Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guerin relapsing non-muscle-invasive bladder cancer
    Matsumoto, Kazuhiro
    Kikuchi, Eiji
    Shirakawa, Hiroshi
    Hayakawa, Nozomi
    Tanaka, Nobuyuki
    Ninomiya, Akiharu
    Miyajima, Akira
    Nakamura, So
    Oya, Mototsugu
    BJU INTERNATIONAL, 2012, 110 (11B) : E508 - E513
12345